Relationships between structure and four types of pharmacologic activity in arylacetydroxamic acids.
D000632:Aminopyrine / Q000627:therapeutic use; D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001241:Aspirin / Q000627:therapeutic use; D002626:Chemistry, Pharmaceutical; D002986:Clinical Trials as Topic; D004558:Electric Stimulation; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D008297:Male; D051379:Mice; D009132:Muscles / Q000494:pharmacology; D010648:Phenylacetates / Q000627:therapeutic use; D010919:Placebos; D011817:Rabbits; D051381:Rats
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D006877:Hydroxamic Acids; D010648:Phenylacetates; D010919:Placebos; D000632:Aminopyrine; D001241:Aspirin